15年经验:老年局部区域食管癌的多模式治疗含食管切除术
老年组术前ASA和Charlson评分更差、术后房颤和尿潴留更多,但严重并发症率、围术期死亡率和住院时间相似,5年年龄校正生存率老年组44.8%对年轻组39%(无统计学差异)。结论认为老年患者应评估最佳根治性治疗。
要点
- 70岁及以上局部晚期食管癌患者应评估含新辅助放化疗和手术的根治性治疗
- 老年组术前合并症评分更差,但严重并发症和围术期死亡率与年轻组相似
- 老年组术后房颤和尿潴留更常见,需加强术后监测
核心结论
- 70岁及以上局部晚期食管或食管胃结合部癌患者应评估最佳根治性治疗,包括新辅助放化疗和手术切除。
- 尽管老年组术前风险评分和术后房性心律失常更高,但短期和长期结局不劣于年轻患者。
研究设计与样本
- 老年组定义为70岁及以上,年轻组为70岁以下。
主要发现
- 老年组术前美国麻醉医师协会评分和Charlson合并症指数显著更差。
- 老年组术后心房颤动和尿潴留发生率更高。
- 术后Clavien-Dindo并发症严重程度评分3分及以上比率、围术期死亡率和住院时间两组相似。
- 5年年龄校正生存率老年组为44.8%,年轻组为39%(无统计学差异)。
临床怎么用
- 对70岁及以上局部晚期食管或食管胃结合部癌患者,不应仅因年龄而排除根治性多模式治疗。
- 老年患者术前应评估合并症和风险评分,术后注意监测房性心律失常和尿潴留。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Optimal curative therapy for locally advanced esophageal and esophagogastric junction (EGJ) cancer might not be offered to elderly patients due to patient and treating physician perception of the high risk of therapy. To understand the risk of multimodality curative therapy, including surgical resection in the elderly population, we studied our experience with curative therapy in this patient population and compared the risks and outcomes with those in a younger population. STUDY DESIGN: Between January 1, 2004 and December 31, 2019, four hundred and five consecutive patients with esophageal or EGJ cancer underwent primary treatment at our institution, including esophagectomy. Data collected included demographic information, tumor stage, preoperative Charlson Comorbidity Index scores, treatment variables, and short- and long-term outcomes. Patients who were 70 years or older were classified as the "older" group and patients younger than 70 years were "younger." RESULTS: One hundred and eighty-eight younger (mean age 59 years) and 94 older (mean age 74 years) patients received neoadjuvant chemoradiotherapy and surgical resection for stage II and higher cancer. Preoperative American Society of Anesthesiologist and Charlson Comorbidity Index scores were significantly worse in the older group. Postoperative atrial fibrillation and urinary retention developed more often in the older group. Despite this, the rate of postoperative Clavien-Dindo complication severity scores of 3 or higher, perioperative mortality rates, and lengths of stay were similar. Long-term age-adjusted survival rate was 44.8% at 5 years for the group 70 years or older and 39% for the group younger than 70 years (NS). CONCLUSIONS: Patients 70 years and older with locally advanced esophageal or EGJ cancer should be evaluated for optimal curative therapy including neoadjuvant chemoradiotherapy and surgical resection. Although preoperative risk scoring and postoperative atrial arrythmias are higher in the older group, short- and long-term outcomes are not inferior in these patients.
引用
- Sawyer WP, Luo X, Welch AM, et al. 15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer. J Am Coll Surg. 2021. PMID: 33549634. doi:10.1016/j.jamcollsurg.2020.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。